ABBOTT LABORATORIES (PAKISTAN) LTDABBOTT LABORATORIES (PAKISTAN) LTDABBOTT LABORATORIES (PAKISTAN) LTD

ABBOTT LABORATORIES (PAKISTAN) LTD

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪115.72 B‬PKR
51.11PKR
‪261.78 M‬PKR
‪55.48 B‬PKR
‪16.57 M‬
Beta (1Y)
1.07
Employees (FY)
‪1.43 K‬
Change (1Y)
−33 −2.26%
Revenue / Employee (1Y)
‪38.79 M‬PKR
Net income / Employee (1Y)
‪183.06 K‬PKR

About ABBOTT LABORATORIES (PAKISTAN) LTD


CEO
Syed Anis Ahmed
Headquarters
Karachi
Website
Founded
1948
ISIN
PK0025701019
FIGI
BBG000BJ59C7
Abbott Laboratories Pakistan Ltd. engages in the manufacture, import, and marketing of pharmaceutical, nutritional, diagnostic, diabetes care, molecular devices, hospital, and consumer products. It operates through the following segments: Pharmaceutical, Nutritional, Diagnostics, and Others. The Pharmaceutical segment deals with the manufacture, import, and marketing of research based pharmaceutical products registered with the Drug Regulatory Authority of Pakistan. The Nutritional segment imports and markets pediatric nutritional products and medical nutritional products. The Diagnostics segment covers the import and marketing of diagnostic equipment, molecular devices, and testing kits. The Others segment represents the import and marketing of diabetes care products and manufacturing and marketing of general healthcare products. The company was founded on July 2, 1948 and is headquartered in Karachi, Pakistan.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of ABOT is 1,181.99 PKR — it has decreased by −0.66% in the past 24 hours. Watch ABBOTT LABORATORIES (PAKISTAN) LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on PSX exchange ABBOTT LABORATORIES (PAKISTAN) LTD stocks are traded under the ticker ABOT.
ABOT stock has risen by 1.45% compared to the previous week, the month change is a 9.66% rise, over the last year ABBOTT LABORATORIES (PAKISTAN) LTD has showed a 162.66% increase.
ABOT reached its all-time high on Dec 17, 2024 with the price of 1,299.00 PKR, and its all-time low was 195.51 PKR and was reached on Jan 10, 2013. View more price dynamics on ABOT chart.
See other stocks reaching their highest and lowest prices.
ABOT stock is 2.71% volatile and has beta coefficient of 1.07. Track ABBOTT LABORATORIES (PAKISTAN) LTD stock price on the chart and check out the list of the most volatile stocks — is ABBOTT LABORATORIES (PAKISTAN) LTD there?
Today ABBOTT LABORATORIES (PAKISTAN) LTD has the market capitalization of ‪115.72 B‬, it has increased by 10.73% over the last week.
Yes, you can track ABBOTT LABORATORIES (PAKISTAN) LTD financials in yearly and quarterly reports right on TradingView.
ABBOTT LABORATORIES (PAKISTAN) LTD is going to release the next earnings report on Feb 26, 2025. Keep track of upcoming events with our Earnings Calendar.
ABOT net income for the last quarter is ‪1.81 B‬ PKR, while the quarter before that showed ‪621.38 M‬ PKR of net income which accounts for 191.15% change. Track more ABBOTT LABORATORIES (PAKISTAN) LTD financial stats to get the full picture.
ABBOTT LABORATORIES (PAKISTAN) LTD dividend yield was 0.00% in 2023, and payout ratio reached 0.00%. The year before the numbers were 3.24% and 48.88% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 22, 2024, the company has ‪1.43 K‬ employees. See our rating of the largest employees — is ABBOTT LABORATORIES (PAKISTAN) LTD on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ABBOTT LABORATORIES (PAKISTAN) LTD EBITDA is ‪8.47 B‬ PKR, and current EBITDA margin is 7.35%. See more stats in ABBOTT LABORATORIES (PAKISTAN) LTD financial statements.
Like other stocks, ABOT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ABBOTT LABORATORIES (PAKISTAN) LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ABBOTT LABORATORIES (PAKISTAN) LTD technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ABBOTT LABORATORIES (PAKISTAN) LTD stock shows the strong buy signal. See more of ABBOTT LABORATORIES (PAKISTAN) LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.